Meta to Layoff 20%, AI Cured Dogs Cancer, Nvidia's New Chip

A technology entrepreneur in Australia with no biology background used ChatGPT and Google's AlphaFold—a protein-structure prediction tool—to analyze his dog's tumor after veterinarians gave the animal only months to live. By having the dog's healthy DNA sequenced alongside tumor DNA, converting the tissue data into a format AI tools could process, and using ChatGPT to identify the mutations driving the cancer, he was able to collaborate with researchers at the University of New South Wales to design a custom mRNA vaccine (a vaccine that instructs cells to produce an immune response targeting specific mutations) tailored to that individual tumor. The tumor shrank approximately 75% between December and March and continues to shrink. The discussion frames this as potentially the first personalized cancer vaccine created for a dog, and notes that the scientific work was completed faster than regulatory approval—which took three months on its own. The broader implication is that the same approach is already being tested in humans by Moderna, Merck, and BioNTech, though regulatory timelines for human applications are expected to extend the availability of such treatments by years. The case illustrates how AI tools are lowering the barrier to sophisticated biomedical problem-solving, even for non-specialists.

Nvidia's annual GPU Technology Conference (GTC) is expected to feature the unveiling of the company's next-generation AI chips, with CEO Jensen Huang presenting. The discussion characterizes the current moment as a shift from model training to large-scale inference—the process of running trained AI models in real-world applications at high volume. Inference compute demand is described as "exploding" as companies move from building AI to deploying it everywhere. Nvidia is positioned as the central infrastructure provider for this phase of the AI economy. Each new chip generation is described as resetting the performance ceiling for the entire industry, with the implication that a significant leap at GTC would accelerate adoption across the ecosystem broadly.

OpenAI is reportedly in discussions with private equity firms TPG, Bain Capital, Advent, and Brookfield to launch a joint venture valued at approximately $10 billion, with roughly $4 billion in outside investment. The strategic logic is distinct from standard enterprise sales: rather than selling software company by company, OpenAI would gain access to the entire portfolio holdings of major PE firms—thousands of companies across diverse industries—enabling rapid, coordinated deployment. The discussion references an Anthropic report finding significant gaps between where AI performs well and where it is actually being used. Engineers were cited as a specific example: AI is capable of handling many engineering tasks, yet fewer than 2% of architectural engineers are currently integrating AI into their workflows. The PE partnership model is presented as a mechanism to close those gaps at scale, though an open question remains whether portfolio companies are already using competing AI platforms from Google, Anthropic, or others.

According to a Reuters report, Meta's senior leadership has been asked to prepare plans to reduce the company's workforce by more than 20%—potentially affecting over 15,000 of approximately 79,000 employees. If executed, this would surpass Meta's 2022 layoff of 11,000 people, which was already among the largest in the company's history. Meta has not confirmed the report. Meta's stock rose approximately 3% following the leak. The workforce reduction is framed as directly tied to an aggressive AI capital expenditure plan. Meta projects AI-related infrastructure spending of $115 billion to $135 billion in the current year alone, as part of an estimated $700 billion in combined AI capex planned across Amazon, Microsoft, Alphabet, and Meta over the coming years. CEO Mark Zuckerberg has described 2026 as the year Meta pursues what he calls "personalized super intelligence." The company invested $14.3 billion in Scale AI last year and has reportedly signed AI researchers to contracts worth up to $1 billion over multi-year terms. Meta is not alone. Block announced layoffs affecting approximately 4,000 employees (roughly 40% of its workforce), Amazon is cutting 16,000 roles, and Atlassian has announced a 10% workforce reduction with funds redirected to AI. A consulting firm cited in the discussion, Challenger, Gray & Christmas, has attributed more than 12,000 U.S. job cuts this year directly to AI. The discussion acknowledges that some companies may be using AI as a convenient justification for cost-cutting that would have occurred regardless, but maintains that genuine productivity gains are reducing headcount requirements even as revenue grows. The discussion anticipates a cyclical pattern: an initial wave of reductions followed by rehiring oriented around AI-native skills, as companies find a new operational equilibrium. --- Key takeaways: - **Personalized AI-driven medicine is no longer theoretical.** A non-specialist produced a functional, tumor-specific mRNA vaccine using commercially available AI tools; the primary bottleneck was regulatory approval, not scientific capability. - **The AI economy has shifted from training to deployment.** Nvidia's next chip generation and the explosion in inference compute demand signal that the infrastructure buildout is entering a new, operationally intensive phase. - **Private equity is emerging as an AI distribution channel.** The OpenAI-PE joint venture model represents a structural shortcut to enterprise adoption, bypassing individual sales cycles in favor of portfolio-wide rollouts across thousands of companies simultaneously. - **Workforce reallocation is accelerating and broadening beyond tech.** Meta's potential 20%-plus cut, combined with similar moves at Amazon, Block, and Atlassian, suggests that AI-driven headcount reduction is becoming a standard strategic lever, not an anomaly. - **Capital concentration in AI infrastructure is intensifying.** The $700 billion combined capex figure across four major tech companies indicates that competitive advantage in AI will increasingly depend on infrastructure scale, making the gap between well-capitalized incumbents and smaller players structurally wider.